Skip to main content
Erschienen in: Clinical Oral Investigations 3/2010

01.06.2010 | Original Article

Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings

verfasst von: Sebastian Hoefert, Inge Schmitz, Andrea Tannapfel, Harald Eufinger

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model. Bone samples from 35 patients with ONJ were analyzed. Control samples were taken from five patients with osteomyelitis (OM), ten patients with osteoradionecrosis, seven patients with osteoporosis and bisphosphonate medication without signs of ONJ, and six osteoporotic elderly patients. Samples were examined using scanning electron microscopy. In 54% of the bone samples of patients with ONJ, microcracks were seen. Inflammatory and connective tissue reactions within the microcracks were evident in 82% of the cases, indicating that these cracks were not artificial. In contrast, only 29% of samples from patients with oral bisphosphonate medication without ONJ, no sample from patients with OM, none of the osteoradionecrosis group, and only 17% from patients with osteoporosis showed microcracks. Statistically significant differences could be found between the ONJ group and the group after irradiation and the group with OM, respectively. The evidence of microcracks could be a first step in the pathogenesis of bisphosphonate-related ONJ. The accumulation of these microcracks leads to a situation that could be named “non-symptomatic ONJ”. Disruptions of the mucosal integrity may then allow bacterial invasion, leading to jawbone infection with exposed bone, fistulas, and pain. This state could be called “symptomatic ONJ”. Furthermore, an assumed local immunosuppression as indicated by various studies could explain the severe courses of therapy-resistant ONJ as regularly observed.
Literatur
1.
Zurück zum Zitat Abu-Id MH, Acil Y, Gottschalk J, Kreusch T (2006) Bisphosphonatassoziierte Osteonekrose des Kiefers. Mund Kiefer Gesichtschir 10:73–81CrossRefPubMed Abu-Id MH, Acil Y, Gottschalk J, Kreusch T (2006) Bisphosphonatassoziierte Osteonekrose des Kiefers. Mund Kiefer Gesichtschir 10:73–81CrossRefPubMed
2.
Zurück zum Zitat Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66:987–994CrossRefPubMed Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66:987–994CrossRefPubMed
3.
Zurück zum Zitat Altundal H, Guevener OE (2004) The effect of alendronate on resorption of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg 33:286–293CrossRefPubMed Altundal H, Guevener OE (2004) The effect of alendronate on resorption of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg 33:286–293CrossRefPubMed
4.
Zurück zum Zitat Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T (2006) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24:945–952CrossRefPubMed Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T (2006) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24:945–952CrossRefPubMed
5.
Zurück zum Zitat Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Papadimitriou C, Terpos E, Dimopoulos A (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580–8587CrossRefPubMed Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Papadimitriou C, Terpos E, Dimopoulos A (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580–8587CrossRefPubMed
6.
Zurück zum Zitat Bouvier M, Hylander WL (1981) Effect of bone strain on cortical bone structure in macaques (Macaca mulatta). J Morph 167:1–12CrossRefPubMed Bouvier M, Hylander WL (1981) Effect of bone strain on cortical bone structure in macaques (Macaca mulatta). J Morph 167:1–12CrossRefPubMed
7.
Zurück zum Zitat Bras J, de Jonge HKT, van Merkensteyn JPR (1990) Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 11:244–250CrossRefPubMed Bras J, de Jonge HKT, van Merkensteyn JPR (1990) Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 11:244–250CrossRefPubMed
8.
Zurück zum Zitat Bukowski JF, Dascher CC, Das H (2005) Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 328:746–750CrossRefPubMed Bukowski JF, Dascher CC, Das H (2005) Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 328:746–750CrossRefPubMed
9.
Zurück zum Zitat Burr DB, Hooser M (1995) Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 17:431–433CrossRefPubMed Burr DB, Hooser M (1995) Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 17:431–433CrossRefPubMed
10.
Zurück zum Zitat Burr DB, Stafford T (1990) Validity of the bulk staining technique to separate artificial from in vivo bone microdamage. Clin Orthop Relat Res 260:305–308PubMed Burr DB, Stafford T (1990) Validity of the bulk staining technique to separate artificial from in vivo bone microdamage. Clin Orthop Relat Res 260:305–308PubMed
11.
Zurück zum Zitat Burr DB, Martin RB, Schaffler MB, Radin EL (1985) Bone remodeling in response to in vivo fatigue microdamage. J Biomech 18:189–200CrossRefPubMed Burr DB, Martin RB, Schaffler MB, Radin EL (1985) Bone remodeling in response to in vivo fatigue microdamage. J Biomech 18:189–200CrossRefPubMed
12.
Zurück zum Zitat Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252–260PubMed Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252–260PubMed
13.
Zurück zum Zitat Day JS, Ding M, Bednarz P, van der Linden JC, Mashiba T, Hirano T, Johnston CC, Burr DB, Hvid I, Sumner DR, Weinans H (2004) Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22:465–471CrossRefPubMed Day JS, Ding M, Bednarz P, van der Linden JC, Mashiba T, Hirano T, Johnston CC, Burr DB, Hvid I, Sumner DR, Weinans H (2004) Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22:465–471CrossRefPubMed
14.
Zurück zum Zitat Dechow PC, Hylander WL (2000) Elastic properties and masticatory bone stress in the macaque mandible. Am J Phys Anthropol 112:553–574CrossRefPubMed Dechow PC, Hylander WL (2000) Elastic properties and masticatory bone stress in the macaque mandible. Am J Phys Anthropol 112:553–574CrossRefPubMed
15.
Zurück zum Zitat Dicuonzo G, Vincenzi B, Santini D, Avvisati L, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G (2003) Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 23:649–654CrossRefPubMed Dicuonzo G, Vincenzi B, Santini D, Avvisati L, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G (2003) Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 23:649–654CrossRefPubMed
16.
Zurück zum Zitat Dieli F, Gebbia N, Poccia F, Gaccamo N, Montesano C, Fulfaro F, Arcara C, Valerio MR, Meraviglia S, Di Sano C, Sireci G, Salerno A (2003) Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 102:2310–2311CrossRefPubMed Dieli F, Gebbia N, Poccia F, Gaccamo N, Montesano C, Fulfaro F, Arcara C, Valerio MR, Meraviglia S, Di Sano C, Sireci G, Salerno A (2003) Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 102:2310–2311CrossRefPubMed
17.
Zurück zum Zitat Enzendam J, Kosterman K, Spijkerboer H, Bleumink R, Hassing I, van Rooijen N, Vos JG, Pieters R (2005) Macrophages are involved in hexachlorobenzene-induced adverse effects. Toxicol Appl Pharmacol 209:19–27CrossRef Enzendam J, Kosterman K, Spijkerboer H, Bleumink R, Hassing I, van Rooijen N, Vos JG, Pieters R (2005) Macrophages are involved in hexachlorobenzene-induced adverse effects. Toxicol Appl Pharmacol 209:19–27CrossRef
18.
Zurück zum Zitat Frost HM (1960) Presence of microscopic cracks in vivo in bone. Henry Ford Hosp Med Bull 8:25–35 Frost HM (1960) Presence of microscopic cracks in vivo in bone. Henry Ford Hosp Med Bull 8:25–35
19.
Zurück zum Zitat Hansen T, Kunkel M, Kirkpatrick CJ, Weber A (2006) Actimomyces in infected osteoradionecrosis—underestimated? Human Pathol 37:61–67CrossRef Hansen T, Kunkel M, Kirkpatrick CJ, Weber A (2006) Actimomyces in infected osteoradionecrosis—underestimated? Human Pathol 37:61–67CrossRef
20.
Zurück zum Zitat Hansen T, Kunkel M, Weber A, Kirkpatrick CJ (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155–160CrossRefPubMed Hansen T, Kunkel M, Weber A, Kirkpatrick CJ (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates—histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155–160CrossRefPubMed
21.
Zurück zum Zitat Hansen T, Wagner W, Kirkpatrick CJ, Kunkel M (2006) Infected osteoradionecrosis of the mandible: follow-up study suggests deterioration in outcome for patients with actinomyces-positive bone biopsies. Int J Oral Maxillofac Surg 35:1001–1004CrossRefPubMed Hansen T, Wagner W, Kirkpatrick CJ, Kunkel M (2006) Infected osteoradionecrosis of the mandible: follow-up study suggests deterioration in outcome for patients with actinomyces-positive bone biopsies. Int J Oral Maxillofac Surg 35:1001–1004CrossRefPubMed
22.
Zurück zum Zitat Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682–689CrossRefPubMed Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682–689CrossRefPubMed
23.
Zurück zum Zitat Hess LM, Jeter NJ, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121:475–483CrossRefPubMed Hess LM, Jeter NJ, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121:475–483CrossRefPubMed
24.
Zurück zum Zitat Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobishosphonates is inhibited by statins. Clin Exp Immunol 139:101–111CrossRefPubMed Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobishosphonates is inhibited by statins. Clin Exp Immunol 139:101–111CrossRefPubMed
25.
Zurück zum Zitat Hoefert S, Eufinger H (2006) Nekrosen der Kieferknochen unter Bisphosphonattherapie. Orthopäde 35:204–209CrossRefPubMed Hoefert S, Eufinger H (2006) Nekrosen der Kieferknochen unter Bisphosphonattherapie. Orthopäde 35:204–209CrossRefPubMed
26.
Zurück zum Zitat Hoefert S, Wierich W, Eufinger H, Krempien B (2006) BP-associated avascular necrosis (AN) of the jaws: histological findings. Bone 38(Suppl):76CrossRef Hoefert S, Wierich W, Eufinger H, Krempien B (2006) BP-associated avascular necrosis (AN) of the jaws: histological findings. Bone 38(Suppl):76CrossRef
27.
Zurück zum Zitat Hu JH, Ding M, Soballe K, Bechtold JE, Danielsen CC, Days JS, Hvid I (2002) Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone. Bone 31:591–597CrossRefPubMed Hu JH, Ding M, Soballe K, Bechtold JE, Danielsen CC, Days JS, Hvid I (2002) Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone. Bone 31:591–597CrossRefPubMed
28.
Zurück zum Zitat Huja SS, Hasan MS, Pidaparti R, Turner CH, Garetto LP, Burr DB (1999) Development of a fluorescent light technique for evaluating microdamage in bone subjected to fatigue loading. J Biomech 32:1243–1249CrossRefPubMed Huja SS, Hasan MS, Pidaparti R, Turner CH, Garetto LP, Burr DB (1999) Development of a fluorescent light technique for evaluating microdamage in bone subjected to fatigue loading. J Biomech 32:1243–1249CrossRefPubMed
29.
Zurück zum Zitat Huk OL, Zukor DJ, Antoniou J, Petit A (2003) Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis. J Orthop Res 21:81–87CrossRefPubMed Huk OL, Zukor DJ, Antoniou J, Petit A (2003) Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis. J Orthop Res 21:81–87CrossRefPubMed
30.
Zurück zum Zitat Jereczek-Fossa BA, Orechia R (2002) Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28:65–74CrossRefPubMed Jereczek-Fossa BA, Orechia R (2002) Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28:65–74CrossRefPubMed
31.
Zurück zum Zitat Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Lillian Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of the task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479–1491CrossRefPubMed Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Lillian Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of the task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479–1491CrossRefPubMed
32.
Zurück zum Zitat Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha LA, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839–847CrossRefPubMed Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha LA, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839–847CrossRefPubMed
33.
Zurück zum Zitat Lee TC, Mohsin S, Taylor D, Parkesh R, Gunnlaugsson T, O’Brien FJ, Giehl M, Gowin W (2003) Detecting microdamage in bone. J Anat 203:161–172CrossRefPubMed Lee TC, Mohsin S, Taylor D, Parkesh R, Gunnlaugsson T, O’Brien FJ, Giehl M, Gowin W (2003) Detecting microdamage in bone. J Anat 203:161–172CrossRefPubMed
34.
Zurück zum Zitat Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldank MJ, Verbon A, Deventer SJH, van der Poll T (2001) Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 166:4604–4611PubMed Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldank MJ, Verbon A, Deventer SJH, van der Poll T (2001) Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 166:4604–4611PubMed
35.
Zurück zum Zitat Li J, Mashiba T, Burr DB (2001) Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Cacif Tissue Int 69:281–286CrossRef Li J, Mashiba T, Burr DB (2001) Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Cacif Tissue Int 69:281–286CrossRef
36.
Zurück zum Zitat Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1118CrossRefPubMed Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1118CrossRefPubMed
37.
Zurück zum Zitat Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575CrossRefPubMed Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575CrossRefPubMed
39.
Zurück zum Zitat Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21:253–254CrossRef Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21:253–254CrossRef
40.
Zurück zum Zitat Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Sook-Bin MS (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. An American academy of oral medicine position paper. JADA 136:1658–1668PubMed Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Sook-Bin MS (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. An American academy of oral medicine position paper. JADA 136:1658–1668PubMed
41.
Zurück zum Zitat Moreau MF, Guillet C, Massin P, Chavalier S, Gascan H, Basle MF, Chapparad D (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73:718–723CrossRefPubMed Moreau MF, Guillet C, Massin P, Chavalier S, Gascan H, Basle MF, Chapparad D (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73:718–723CrossRefPubMed
42.
Zurück zum Zitat O’Brien FJ, Brennan O, Kennedy OD, Lee C (2005) Microcracks in cortical bone: how do they affect bone biology? Curr Osteoporos Rep 3:39–45CrossRefPubMed O’Brien FJ, Brennan O, Kennedy OD, Lee C (2005) Microcracks in cortical bone: how do they affect bone biology? Curr Osteoporos Rep 3:39–45CrossRefPubMed
43.
Zurück zum Zitat Odvina CV, Zerwkh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294–1301CrossRefPubMed Odvina CV, Zerwkh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294–1301CrossRefPubMed
44.
Zurück zum Zitat Ott SM (2005) Editoral: long-term safety of bisphosphonates. J Clin Endocrinol Metab 90:1897–1899CrossRefPubMed Ott SM (2005) Editoral: long-term safety of bisphosphonates. J Clin Endocrinol Metab 90:1897–1899CrossRefPubMed
45.
Zurück zum Zitat Papapoulos SE (2001) Catabolic and anabolic signals in bone: therapeutic implications. Curr Opin Clin Nutr Metab Care 4:191–196CrossRefPubMed Papapoulos SE (2001) Catabolic and anabolic signals in bone: therapeutic implications. Curr Opin Clin Nutr Metab Care 4:191–196CrossRefPubMed
46.
Zurück zum Zitat Peleg M, Lopez EAL (2006) The treatment of osteoradionecrosis of the mandible: the case for hyperbaric oxygen and bone graft reconstruction. J Oral Maxillofac Surg 64:956–960CrossRefPubMed Peleg M, Lopez EAL (2006) The treatment of osteoradionecrosis of the mandible: the case for hyperbaric oxygen and bone graft reconstruction. J Oral Maxillofac Surg 64:956–960CrossRefPubMed
47.
Zurück zum Zitat Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphophonates and calcitonin. J Clin Invest 104:1363–1374CrossRefPubMed Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphophonates and calcitonin. J Clin Invest 104:1363–1374CrossRefPubMed
48.
Zurück zum Zitat Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 47:318–320CrossRef Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 47:318–320CrossRef
49.
Zurück zum Zitat Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841–847CrossRefPubMed Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841–847CrossRefPubMed
50.
Zurück zum Zitat Ruggiero SL, Mehrotra B, Rosenberg T, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527–534CrossRefPubMed Ruggiero SL, Mehrotra B, Rosenberg T, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527–534CrossRefPubMed
51.
Zurück zum Zitat Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433–441CrossRefPubMed Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:433–441CrossRefPubMed
52.
Zurück zum Zitat Sarin J, DeRossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277–285CrossRefPubMed Sarin J, DeRossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277–285CrossRefPubMed
53.
Zurück zum Zitat Schaffler MB, Pitchford K, Choi K, Riddle M (1994) Examination of compact bone microdamage using back-scattered electron microscopy. Bone 15:483–488CrossRefPubMed Schaffler MB, Pitchford K, Choi K, Riddle M (1994) Examination of compact bone microdamage using back-scattered electron microscopy. Bone 15:483–488CrossRefPubMed
54.
Zurück zum Zitat Sedghizadeh PP, Kumar SKS, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbiofilms in osteonecrosis of the jaws secondary to bisphosphonte therapy. J Oral Maxillofac Surg 66:767–775CrossRefPubMed Sedghizadeh PP, Kumar SKS, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbiofilms in osteonecrosis of the jaws secondary to bisphosphonte therapy. J Oral Maxillofac Surg 66:767–775CrossRefPubMed
55.
Zurück zum Zitat Takagi K, Takagi M, Kanangat S, Warrington KJ, Shigemitsu H, Postlethwaite AE (2005) Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways. J Immunol 174:1801–1810PubMed Takagi K, Takagi M, Kanangat S, Warrington KJ, Shigemitsu H, Postlethwaite AE (2005) Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways. J Immunol 174:1801–1810PubMed
56.
Zurück zum Zitat van Poznak C (2006) The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer. Cancer Invest 24:110–112CrossRefPubMed van Poznak C (2006) The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer. Cancer Invest 24:110–112CrossRefPubMed
57.
Zurück zum Zitat Wannfors K, Hammarström L (1985) Infectious foci in chronic osteomyelitis of the jaws. Int J Oral Surg 14:493–503CrossRefPubMed Wannfors K, Hammarström L (1985) Infectious foci in chronic osteomyelitis of the jaws. Int J Oral Surg 14:493–503CrossRefPubMed
Metadaten
Titel
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings
verfasst von
Sebastian Hoefert
Inge Schmitz
Andrea Tannapfel
Harald Eufinger
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Oral Investigations / Ausgabe 3/2010
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-009-0300-6

Weitere Artikel der Ausgabe 3/2010

Clinical Oral Investigations 3/2010 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.